In an analysis of both the CLARITY and CLARITY Extension studies, Cladribine tablets showed strong efficacy and a good safety profile. No cancers were observed.Medscape Medical News (Source: Medscape Medical News Headlines)

Read full article on RSS Statement

Most of the information found on this website comes from RSS Feeds. It is an automated task that provides the information to you. We try to limit items that are duplicates, but with many feeds this can be difficult. Since the owner of this website also has MS and is legally blind this service was necessary to keep the website running with as much automation as possible. Volunteers help from time to time but many have disabilities themselves. We thank you for visiting us and hope that MSC can be of service to you and your loved ones.